Cholinesterase inhibitors for treatment of dementia associated with Parkinson's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 76, Issue 7, 2005, Pages 903-904

  Cummings, Jeffrey L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; DOPAMINE RECEPTOR STIMULATING AGENT; PSYCHOTROPIC AGENT; RIVASTIGMINE;

ALZHEIMER DISEASE; CHOLINERGIC SYSTEM; CHOLINESTERASE INHIBITION; COGNITION; COGNITIVE DEFECT; DEMENTIA; DRUG EFFICACY; EDITORIAL; HUMAN; MAJOR CLINICAL STUDY; MINI MENTAL STATE EXAMINATION; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE; TREATMENT OUTCOME;

EID: 21344463805     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2004.061499     Document Type: Editorial

References (8)

1. Aarsland D, Andersen K, Larsen JP, et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003;60:387-92.
2. Hurtig H, Trojanowski JQ, Galvin J, et al. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 2000;54:1916-21.
3. Bohnen NI, Kaufer DI, Ivanco LS, et al. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol 2003;60:1745-8.
4. Ravina B, Putt M, Siderowf A, et al. Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study. J Neurol Neurosurg Psychiatry 2005;76:934-9.
5. Emre M, Aarsland D, Albonese A, et al. Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med 2004;351:2509-18.
6. Aarsland D, Laake K, Larsen JP, et al. Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study. J Neurol Neurosurg Psychiatry 2002;72:708-12.
7. Aarsland D, Hutchinson M, Larsen JP. Cognitive, psychiatric and motor response to galantomine in Parkinson's disease with dementia. Int J Geriatr Psychiatry 2003;18:937-41.
8. Hutchinson M, Fazzini E. Cholinesterase inhibition in Parkinson's disease. J Neurol Neurosurg Psychiatry 1996;61:324-5.